Target
Transcription initiation factor TFIID subunit 1 [1381-1497]
Ligand
BDBM346492
Substrate
n/a
Meas. Tech.
TAF1-BD1 TR-FRET Binding Assay
IC50
216±n/a nM
Citation
 Adler, MBurdick, DJCrawford, TDuplessis, MMagnuson, SRNasveschuk, CGRomero, FATang, YTsui, VHWang, S Therapeutic compounds and uses thereof US Patent  US10202378 Publication Date 2/12/2019
Target
Name:
Transcription initiation factor TFIID subunit 1 [1381-1497]
Synonyms:
BA2R | CCG1 | CCGS | TAF1 | TAF1-BD1 | TAF1-BD1 (aa 1381-1497) | TAF1_HUMAN | TAF2A
Type:
Enzyme Catalytic Domain
Mol. Mass.:
25344.81
Organism:
Homo sapiens (human)
Description:
P21675[1381-1497]
Residue:
217
Sequence:
PMVTLSSILESIINDMRDLPNTYPFHTPVNAKVVKDYYKIITRPMDLQTLRENVRKRLYPSREEFREHLELIVKNSATYNGPKHSLTQISQSMLDLCDEKLKEKEDKLARLEKAINPLLDDDDQVAFSFILDNIVTQKMMAVPDSWPFHHPVNKKFVPDYYKVIVNPMDLETIRKNISKHKYQSRESFLDDVNLILANSVKYNGPESQYTKTAQEIV
  
Inhibitor
Name:
BDBM346492
Synonyms:
3-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-4-(3-cyclopropyl-3-hydroxy-but-1-ynyl)-2,6-dimethyl-1H-pyrrolo[2,3-c]pyridin-7-one | US10202378, Example 187 | US10202378, Example 98a | US10202378, Example 98b
Type:
Small organic molecule
Emp. Form.:
C22H26N4O3
Mol. Mass.:
394.4668
SMILES:
Cc1[nH]c2c(c1-c1nnc(o1)C(C)(C)C)c(cn(C)c2=O)C#CC(C)(O)C1CC1
Structure:
Search PDB for entries with ligand similarity: